Home
Home

fish oil

Some Fish Oil Doesn't Help Some Patients in Some Countries

Some Fish Oil Doesn't Help Some Patients in Some Countries
Motley Fool

Amarin Trouble Grows As Does Evidence Against Fish Oil's Benefits

Amarin Trouble Grows As Does Evidence Against Fish Oil's Benefits
TheStreet.com

Amarin Pushed Closer to Solo Vascepa Launch By Another NCE Delay

Amarin Pushed Closer to Solo Vascepa Launch By Another NCE Delay
The Street

Amarin issues patent update on fish-oil drug

Amarin issues patent update on fish-oil drug
Marketwatch

Amarin falls 11% on insider stock-sale reports

Amarin falls 11% on insider stock-sale reports
Marketwatch

Amarin Wins Approval For Debut Drug To Treat High Blood Fats

Amarin Wins Approval For Debut Drug To Treat High Blood Fats
Bloomberg

AMRN FDA Approval Likely Today

AMRN FDA Approval Likely Today
Forbes

Will the FDA Approve Amarin's AMR101?

Will the FDA Approve Amarin's AMR101?
Motley Fool

Amarin Shares Trade Higher on Hope for Fish-Oil Drug

Amarin Shares Trade Higher on Hope for Fish-Oil Drug
Minyanville

Amarin's Fish Oil: Blazing A New Path Against Cardiovascular Disease

Amarin's Fish Oil: Blazing A New Path Against Cardiovascular Disease
Seeking Alpha